These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15662486)

  • 1. A monoclonal antibody that recognizes Epstein-Barr virus nuclear antigen 2 (EBNA 2) amino acids 1-58 does not react with EBNA 2 in native form, consistent with the self-association of EBNA 2 through the amino-terminus.
    Harada S; Obayashi M; Suzuki C; Kitamura R; Eda H; Kikuta H; Satoh H; Sugihara K; Yanagi K
    Arch Virol; 2005 May; 150(5):1033-43. PubMed ID: 15662486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ; Petti L; Rowe M
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).
    Rumpold H; Rhodes GH; Bloch PL; Carson DA; Vaughan JH
    J Immunol; 1987 Jan; 138(2):593-9. PubMed ID: 2432130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Pratesi F; Tommasi C; Anzilotti C; Chimenti D; Migliorini P
    Arthritis Rheum; 2006 Mar; 54(3):733-41. PubMed ID: 16508937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.
    Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K
    Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against regions topologically surrounding the homodimeric beta-barrel interface of Epstein-Barr virus nuclear antigen-1.
    Eda H; Ishii Y; Obayashi M; Harada S; Ito S; Fujita T; Ikeda M; Kusano S; Kitamura R; Suzuki C; Hara T; Watanabe M; Satoh H; Sugihara K; Yanagi K
    Virus Res; 2005 Apr; 109(1):87-94. PubMed ID: 15826916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a monoclonal antibody against Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) that can detect EBNA-LP expressed in P3HR1 cells.
    Shaku F; Matsuda G; Furuya R; Kamagata C; Igarashi M; Tanaka M; Kanamori M; Nishiyama Y; Yamamoto N; Kawaguchi Y
    Microbiol Immunol; 2005; 49(5):477-83. PubMed ID: 15905610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.
    Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
    Oncogene; 2000 Mar; 19(14):1801-6. PubMed ID: 10777214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein.
    Rhodes GH; Valbracht JR; Nguyen MD; Vaughan JH
    J Autoimmun; 1997 Oct; 10(5):447-54. PubMed ID: 9376072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS; Bertoni G; Takagi S; Sairenji T
    Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
    West MJ; Webb HM; Sinclair AJ; Woolfson DN
    J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibodies to viral peptides.
    Sidorova E; Borisova T; Lyakisheva L; Rosen A
    Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
    J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies elicited in response to EBNA-1 may cross-react with dsDNA.
    Yadav P; Tran H; Ebegbe R; Gottlieb P; Wei H; Lewis RH; Mumbey-Wafula A; Kaplan A; Kholdarova E; Spatz L
    PLoS One; 2011 Jan; 6(1):e14488. PubMed ID: 21245919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.
    Tanner JE; Coinçon M; Leblond V; Hu J; Fang JM; Sygusch J; Alfieri C
    J Virol; 2015 May; 89(9):4932-41. PubMed ID: 25694592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
    Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
    Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.
    Krauer KG; Buck M; Belzer DK; Flanagan J; Chojnowski GM; Sculley TB
    Virology; 2004 Jan; 318(1):280-94. PubMed ID: 14972554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera.
    Sauter M; Mueller-Lantzsch N
    Virus Res; 1987 Aug; 8(2):141-52. PubMed ID: 2823499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.